Emerson (EMR) PT Lowered to $67 at Citi
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rebounds, but yield surge sets stage for weekly losses
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Emerson (EMR) PT Raised to $80 at Stifel
May 3, 2018 3:10 AM EDTStifel raised its price target on Emerson (NYSE: EMR) to $80.00 (from $79.00) while maintaining a Buy rating.
... MoreEmerson (EMR) PT Lowered to $79 at RBC Capital; 'Declares Cycle Not Over'
May 2, 2018 8:25 AM EDTRBC Capital lowered its price target on Emerson (NYSE: EMR) to $79.00 (from $80.00) while maintaining an Outperform rating.
Analyst Deane Dray commented, "Outperform-rated Emersons CEO Dave Farr delivered a booster shot to the sector by asserting that the cycle has not peaked and projecting... More
